These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 33439315)

  • 1. Radiomics signature of brain metastasis: prediction of EGFR mutation status.
    Wang G; Wang B; Wang Z; Li W; Xiu J; Liu Z; Han M
    Eur Radiol; 2021 Jul; 31(7):4538-4547. PubMed ID: 33439315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR-based radiomics predictive modelling of EGFR mutation and HER2 overexpression in metastatic brain adenocarcinoma: a two-centre study.
    Li Y; Jin Y; Wang Y; Liu W; Jia W; Wang J
    Cancer Imaging; 2024 May; 24(1):65. PubMed ID: 38773634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating EGFR from ALK mutation status using radiomics signature based on MR sequences of brain metastasis.
    Li Y; Lv X; Wang B; Xu Z; Wang Y; Gao S; Hou D
    Eur J Radiol; 2022 Oct; 155():110499. PubMed ID: 36049410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting EGFR T790M Mutation in Brain Metastases Using Multisequence MRI-Based Radiomics Signature.
    Li Y; Lv X; Wang B; Xu Z; Wang Y; Sun M; Hou D
    Acad Radiol; 2023 Sep; 30(9):1887-1895. PubMed ID: 36586758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritumoural MRI radiomics signature of brain metastases can predict epidermal growth factor receptor mutation status in lung adenocarcinoma.
    Huang Z; Tu X; Yu T; Zhan Z; Lin Q; Huang X
    Clin Radiol; 2024 Feb; 79(2):e305-e316. PubMed ID: 38000953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric MRI-Based Radiomics Approaches for Preoperative Prediction of EGFR Mutation Status in Spinal Bone Metastases in Patients with Lung Adenocarcinoma.
    Jiang X; Ren M; Shuang X; Yang H; Shi D; Lai Q; Dong Y
    J Magn Reson Imaging; 2021 Aug; 54(2):497-507. PubMed ID: 33638577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Habitat-Based Radiomics for Predicting EGFR Mutations in Exon 19 and 21 From Brain Metastasis.
    Yang C; Fan Y; Zhao D; Wang Z; Wang X; Wang H; Hu Y; He L; Zhang J; Wang Y; Liu Y; Sha X; Su J
    Acad Radiol; 2024 Sep; 31(9):3764-3773. PubMed ID: 38599906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiregional radiomics of brain metastasis can predict response to EGFR-TKI in metastatic NSCLC.
    Fan Y; Wang X; Dong Y; Cui E; Wang H; Sun X; Su J; Luo Y; Yu T; Jiang X
    Eur Radiol; 2023 Nov; 33(11):7902-7912. PubMed ID: 37142868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A deep learning model integrating multisequence MRI to predict EGFR mutation subtype in brain metastases from non-small cell lung cancer.
    Li Y; Lv X; Chen C; Yu R; Wang B; Wang D; Hou D
    Eur Radiol Exp; 2024 Jan; 8(1):2. PubMed ID: 38169047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI-based radiomics analysis for predicting the EGFR mutation based on thoracic spinal metastases in lung adenocarcinoma patients.
    Ren M; Yang H; Lai Q; Shi D; Liu G; Shuang X; Su J; Xie L; Dong Y; Jiang X
    Med Phys; 2021 Sep; 48(9):5142-5151. PubMed ID: 34318502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computed Tomography-Based Radiomics Signature: A Potential Indicator of Epidermal Growth Factor Receptor Mutation in Pulmonary Adenocarcinoma Appearing as a Subsolid Nodule.
    Yang X; Dong X; Wang J; Li W; Gu Z; Gao D; Zhong N; Guan Y
    Oncologist; 2019 Nov; 24(11):e1156-e1164. PubMed ID: 30936378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI-Based Radiomics Nomogram as a Potential Biomarker to Predict the EGFR Mutations in Exon 19 and 21 Based on Thoracic Spinal Metastases in Lung Adenocarcinoma.
    Cao R; Dong Y; Wang X; Ren M; Wang X; Zhao N; Yu T; Zhang L; Luo Y; Cui EN; Jiang X
    Acad Radiol; 2022 Mar; 29(3):e9-e17. PubMed ID: 34332860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomic Signatures for Predicting
    Zheng L; Xie H; Luo X; Yang Y; Zhang Y; Li Y; Yin S; Li H; Xie C
    Front Oncol; 2022; 12():931812. PubMed ID: 35912248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing EGFR mutation molecular subtypes based on MRI radiomics features of lung adenocarcinoma brain metastases.
    Xu J; Yang Y; Gao Z; Song T; Ma Y; Yu X; Shi C
    Clin Neurol Neurosurg; 2024 May; 240():108258. PubMed ID: 38552362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain-Tumor Interface-Based MRI Radiomics Models to Determine EGFR Mutation, Response to EGFR-TKI and T790M Resistance Mutation in Non-Small Cell Lung Carcinoma Brain Metastasis.
    Fan Y; Wang X; Yang C; Chen H; Wang H; Wang X; Hou S; Wang L; Luo Y; Sha X; Yang H; Yu T; Jiang X
    J Magn Reson Imaging; 2023 Dec; 58(6):1838-1847. PubMed ID: 37144750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of MRI-based radiomics signatures as new markers for preoperative assessment of EGFR mutation and subtypes from bone metastases.
    Fan Y; Dong Y; Sun X; Wang H; Zhao P; Wang H; Jiang X
    BMC Cancer; 2022 Aug; 22(1):889. PubMed ID: 35964032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiomics signature: A potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology.
    Tu W; Sun G; Fan L; Wang Y; Xia Y; Guan Y; Li Q; Zhang D; Liu S; Li Z
    Lung Cancer; 2019 Jun; 132():28-35. PubMed ID: 31097090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics evaluates the EGFR mutation status from the brain metastasis: a multi-center study.
    Cao R; Pang Z; Wang X; Du Z; Chen H; Liu J; Yue Z; Wang H; Luo Y; Jiang X
    Phys Med Biol; 2022 Jun; 67(12):. PubMed ID: 35588722
    [No Abstract]   [Full Text] [Related]  

  • 19. Multisequence MRI-based radiomics signature as potential biomarkers for differentiating KRAS mutations in non-small cell lung cancer with brain metastases.
    Lv X; Li Y; Wang B; Wang Y; Xu Z; Hou D
    Eur J Radiol Open; 2024 Jun; 12():100548. PubMed ID: 38298532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accurate prediction of epidermal growth factor receptor mutation status in early-stage lung adenocarcinoma, using radiomics and clinical features.
    Zhu H; Song Y; Huang Z; Zhang L; Chen Y; Tao G; She Y; Sun X; Yu H
    Asia Pac J Clin Oncol; 2022 Dec; 18(6):586-594. PubMed ID: 35098682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.